Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Astellas Completes Acquisition of Mitobridge, Inc.
Thursday, January 25, 2018Astellas Pharma Inc announced that it has completed the acquisition of Mitobridge Inc Mitobridge and Mitobridge has become a wholly owned subsidiary of Astellas as of January US Eastern Time By exercising the option right to acquire Mitobridge A...
Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US
Thursday, January 25, 2018Novartis today announced a licensing agreement with Spark Therapeutics covering development registration and commercialization rights to voretigene neparvovec in markets outside the US Voretigene neparvovec known as LUXTURNATM voretigene neparvovecrz...
ChemDiv Announces Expansion of Multi-Year Hit Identification Collaboration with Janssen
Wednesday, January 24, 2018ChemDiv Inc announced at the th Annual JP Morgan Healthcare Conference the expansion of its hit identification collaboration with Janssen Research Development LLC Janssen and extending it into finding potent antiinfective drug candidates Broadening...
Cardiome Announces Expanded Label For Aggrastat® In China Including New Stemi Indication And High Dose Bolus Regimen
Wednesday, January 24, 2018Cardiome Pharma Corp a revenuegenerating specialty pharmaceutical company focused on commercializing patentprotected hospital drugs today announced that the Chinese Center for Drug Evaluation CDE has approved an expansion of the indications for Aggra...
SillaJen and ABL Europe Expand Strategic Manufacturing Collaboration for Oncolytic Virus Therapies
Tuesday, January 23, 2018SillaJen Inc a clinicalstage biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer and ABL Europe an ABL Inc company providing dedicated viral vector GMP services for gene therapy oncolytic products and va...
Ligand Enters into Worldwide OmniAb® Platform License Agreement with Ferring Pharmaceuticals
Tuesday, January 23, 2018Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide OmniAb platform license agreement with Ferring Pharmaceuticals Under the license Ferring will be able to use the full OmniAb platform including OmniRat OmniMouse OmniFlic a...
Enzychem Lifesciences announces the FDA Orphan Drug Designation granted to EC-18 on Acute Radiation Syndrome (ARS)
Monday, January 22, 2018Enzychem Lifesciences Corp announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation to EC for the treatment of Acute Radiation Syndrome ARS The US FDA Orphan Drug Designation program provides incentives to compani...
Healthcare group Sanofi agrees to buy U.S. peer Bioverativ for $11.6 billion
Monday, January 22, 2018French healthcare group Sanofi has agreed to buy US peer Bioverativ for billion in a deal which Sanofi said would boost its earnings and strengthen its presence in the field of treatments for rare diseases Sanofi has agreed to buy all of the outs...
Tabuk Pharmaceuticals Signs an Exclusive Licensing and Supply Agreement with red otc development GmbH
Saturday, January 20, 2018Tabuk Pharmaceuticals Manufacturing Company one of the leading pharmaceutical companies in the Middle East and North Africa region has entered into an exclusive licensing and supply agreement with red otc development GmbH red otc on Ivy orodispersibl...
Ligand Establishes Program to Develop Captisol-Enabled, Next-Generation Contrast Agents for Diagnostic Imaging
Friday, January 19, 2018Ligand Pharmaceuticals Incorporated announces initiation of a program to develop contrast agents with reduced renal toxicity Contrast agents are injectable solutions used during diagnostic imaging procedures Through this new internallyfunded program...
